# Molecular Dynamics Studies on Trypanosoma cruzi Dihydroorotate Dehydrogenase Complexes: An Analysis of the Inhibitor Influence

## TL;DR

This study uses molecular dynamics to understand how inhibitors affect the enzyme TcDHODH, which is a potential drug target for treating Chagas disease.

## Contribution

The study reveals how ligand size and conformation influence TcDHODH inhibition through detailed molecular dynamics simulations.

## Key findings

- Small ligands maintain a closed enzyme conformation, while larger ones induce open conformations.
- Hydrogen bonds and electrostatic/hydrophobic interactions at subsites S1, S2, and S3 stabilize ligand–enzyme complexes.
- Flexibility in the active site is essential for enzyme function and inhibition.

## Abstract

Chagas disease remains a significant global health problem.
Current
etiological treatment is limited due to its low efficacy in the advanced
stage of the disease and adverse effects. Trypanosoma
cruzi dihydroorotate dehydrogenase (TcDHODH) is a promising target for developing new drugs. This study
explored the structural and dynamic factors influencing its inhibition.
The results from the 100 ns molecular dynamics simulations of 11 ligand–TcDHODH complexes revealed that ligand size and conformation
play crucial roles in enzyme inhibition, with flexibility in the active
site being essential for enzyme function. Small ligands tend to maintain
a closed conformation, while larger ligands induce open conformations.
The results further demonstrate ligand-induced conformational changes
and the role of key hydrogen bonds in stabilizing the ligand–enzyme
complex. Electrostatic and hydrophobic interactions between ligands
and the enzyme’s S1, S2, and S3 subsites contribute to inhibition.
Understanding these factors facilitates the development of potent
and selective TcDHODH inhibitors for the treatment
of Chagas disease.